Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Community-Based Diabetes Screening and Risk Assessment in Rural West Virginia.

Misra R, Fitch C, Roberts D, Wright D.

J Diabetes Res. 2016;2016:2456518. doi: 10.1155/2016/2456518. Epub 2016 Jan 12.

2.

Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes.

Khunti K, Mani H, Achana F, Cooper N, Gray LJ, Davies MJ.

PLoS One. 2015 Sep 1;10(9):e0135702. doi: 10.1371/journal.pone.0135702. eCollection 2015. Review.

3.

The Uptake of Screening for Type 2 Diabetes and Prediabetes by Means of Glycated Hemoglobin versus the Oral Glucose Tolerance Test among 18 to 60-Year-Old People of South Asian Origin: A Comparative Study.

van Valkengoed IG, Vlaar EM, Nierkens V, Middelkoop BJ, Stronks K.

PLoS One. 2015 Aug 28;10(8):e0136734. doi: 10.1371/journal.pone.0136734. eCollection 2015.

4.

Prevalence of Diabetes on Santa Cruz Island in Galapagos Archipelago.

Tufton N, Chowdhury T.

Prev Chronic Dis. 2015 Jun 18;12:E94. doi: 10.5888/pcd12.150108.

5.

A pattern of unspecific somatic symptoms as long-term premonitory signs of type 2 diabetes: findings from the population-based MONICA/KORA cohort study, 1984-2009.

Baumert J, Meisinger C, Lukaschek K, Emeny RT, Rückert IM, Kruse J, Ladwig KH.

BMC Endocr Disord. 2014 Nov 22;14:87. doi: 10.1186/1472-6823-14-87.

6.

Making a case for community screening services: findings from a medical outreach in ibadan, Nigeria.

Adebayo AM, Ige OK, Ilesanmi OS, Ogunniyan TB, Ojo T.

Ann Ib Postgrad Med. 2011 Jun;9(1):14-8.

7.

Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.

Janghorbani M, Adineh H, Amini M.

Rev Diabet Stud. 2013 Winter;10(4):283-92. doi: 10.1900/RDS.2013.10.283. Epub 2014 Feb 10.

8.
9.

Causal beliefs and perceptions of risk for diabetes and cardiovascular disease, The Netherlands, 2007.

Claassen L, Henneman L, Nijpels G, Dekker J, Marteau T, Timmermans D.

Prev Chronic Dis. 2011 Nov;8(6):A130. Epub 2011 Oct 17.

10.

Long-term exposure to traffic-related air pollution and type 2 diabetes prevalence in a cross-sectional screening-study in the Netherlands.

Dijkema MB, Mallant SF, Gehring U, van den Hurk K, Alssema M, van Strien RT, Fischer PH, Nijpels G, Stehouwer CD, Hoek G, Dekker JM, Brunekreef B.

Environ Health. 2011 Sep 5;10:76. doi: 10.1186/1476-069X-10-76.

11.

Lay perceptions of predictive testing for diabetes based on DNA test results versus family history assessment: a focus group study.

Wijdenes-Pijl M, Dondorp WJ, Timmermans DR, Cornel MC, Henneman L.

BMC Public Health. 2011 Jul 5;11:535. doi: 10.1186/1471-2458-11-535.

12.

Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study.

Sargeant LA, Simmons RK, Barling RS, Butler R, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ.

Diabet Med. 2010 Sep;27(9):995-1003. doi: 10.1111/j.1464-5491.2010.03056.x.

13.

Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.

Zhou X, Pang Z, Gao W, Wang S, Zhang L, Ning F, Qiao Q.

Diabetes Care. 2010 Mar;33(3):545-50. doi: 10.2337/dc09-1410. Epub 2009 Dec 10.

14.

Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark.

Juul L, Sandbaek A, Foldspang A, Frydenberg M, Borch-Johnsen K, Lauritzen T.

Scand J Prim Health Care. 2009;27(4):223-31. doi: 10.3109/02813430903279117.

15.

The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

Echouffo-Tcheugui JB, Simmons RK, Williams KM, Barling RS, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ.

BMC Public Health. 2009 May 12;9:136. doi: 10.1186/1471-2458-9-136.

16.

Family history of diabetes: exploring perceptions of people at risk in the Netherlands.

Pijl M, Henneman L, Claassen L, Detmar SB, Nijpels G, Timmermans DR.

Prev Chronic Dis. 2009 Apr;6(2):A54. Epub 2009 Mar 16.

17.

Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes: a randomized controlled trial.

Pijl M, Timmermans DR, Claassen L, Janssens AC, Nijpels G, Dekker JM, Marteau TM, Henneman L.

Diabetes Care. 2009 Apr;32(4):597-9. doi: 10.2337/dc08-1049. Epub 2009 Jan 8.

18.

Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study.

Janssen PG, Gorter KJ, Stolk RP, Akarsubasi M, Rutten GE.

BMC Fam Pract. 2008 Dec 16;9:67. doi: 10.1186/1471-2296-9-67.

19.

Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study.

Sandbaek A, Griffin SJ, Rutten G, Davies M, Stolk R, Khunti K, Borch-Johnsen K, Wareham NJ, Lauritzen T.

Diabetologia. 2008 Jul;51(7):1127-34. doi: 10.1007/s00125-008-1013-0. Epub 2008 Apr 29.

20.

The impact of new insights and revised practice guidelines on prescribing drugs in the treatment of Type 2 diabetes mellitus.

Lub R, Denig P, van den Berg PB, Hoogenberg K, de Jong-van den Berg LT.

Br J Clin Pharmacol. 2006 Dec;62(6):660-5. Epub 2006 Jun 23.

Supplemental Content

Support Center